# Commission Implementing Regulation (EU) 2017/556 of 24 March 2017 on the detailed arrangements for the good clinical practice inspection procedures pursuant to Regulation (EU) No 536/2014 of the European Parliament and of the Council (Text with EEA relevance), Article 2: Time frame for inspections

Extent: E+W+S+N.I.

Inspections may take place in any of the following circumstances:
(a) before, during or after the conduct of a clinical trial;
(b) as part of the verification of applications for marketing authorisation;
(c) as a follow-up to the granting of a marketing authorisation.

---
Source: https://www.legislation.gov.uk/eur/2017/556/article/2 (the official version)
Page: https://openlegislation.uk/eu-regulation-2017-556/article-2
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.